Skip to main content
. 2015 Jun 17;36(34):2327–2337. doi: 10.1093/eurheartj/ehv253

Figure 3.

Figure 3

Pedigrees of the patients with truncating TTN mutations. All family members with available DNA samples were included. Index patients are marked with an arrow. All family members with dilated cardiomyopathy carried truncating TTN mutation. Disease penetrance increased from 53.8% at age 50 to 84.6% at age 60 and 100.0% at age 70.